On Demand: FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Upcoming Webinars

On Demand: FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Recorded Nov. 30 and Dec. 14

Published: Thursday, November 30, 2017

Event date: 12/14/2017 1:00 PM - 3:00 PM Export event

Legal experts provide an update on FDA inspections, emerging cGMP compliance issues, strategies for responding to an FDA 483 and answers to your specific questions.


Event Details

Dates and Times: 
Part 1 Recorded Nov. 30
Part 2 Recorded Dec. 14

Cost:
$199 (AHPA Members)
$399 (Non-Members)

This webinar helps businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice regulations (21 CFR 111) that have been the primary focus of recent FDA inspections. This knowledge will assist business in allocating and directing their compliance resources.

This two-part webinar provides data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.

Part 1 -- Recorded November 30

Veteran industry legal experts provide an insider's view of the current cGMP enforcement landscape and strategies for compliance. AHPA staff offer a detailed analysis of the association's repository of inspection data, which includes actual FDA 483 inspection reports, observation forms, and establishment inspection reports (EIRs).

A 30-minute Q&A session answers attendees specific questions.

Part 2 -- Recorded December 14

An extended Q&A session addresses attendee questions. Legal experts then provide strategies for companies to effectively respond to an FDA 483 in order to avoid getting a Warning Letter. Learn tips for conducting an FDA inspection.

Topics

  • Own label distributors and contract manufacturers: What are the differences and what aspects of the cGMP are you responsible for during an inspection?
  • Own label distributors and contract manufacturers: What are the differences and what aspects of the cGMP are you responsible for during an inspection?
  • FDA inspection practices and what can be done to prepare
  • Detailed analysis of recent FDA inspection reports
  • Effectively responding to an FDA 483 so as to avoid a Warning Letter
  • FDA inspection do's and don'ts
  • Answers to your questions during the extended Q&A session

Presenters

  • Anthony L. Young, Esq., Partner, Kleinfeld, Kaplan and Becker, LLP / AHPA General Counsel
  • Alan Feldstein, Esq., Of Counsel, Collins Gann McCloskey & Barry PLLC
  • Merle Zimmermann, Ph.D., Information Analyst, AHPA
Print

Webinar Recordings

Free AHPA-CRN Webinar: Brexit Impact on the Marketing of Food Supplements in the EU and UK

Presented in cooperation with IADSA

Recorded August 23, 2016. Member cost: Free. Nonmember cost: $99.

How to Choose a Contract Laboratory

Learn what factors to consider before selecting a contract lab and and how to get your testing completed correctly

Recorded May 18, 2016. Member cost: $199. Nonmember cost: $399.

Free AHPA-UNPA Webinar Prepares Members for a State Attorney General Call

Tips on how your company should respond to a state attorney general's letter of inquiry

Recorded March 24, 2016. Free to members and nonmembers.

Demystifying Microbiology for the Herbal Product and Dietary Supplement Industries

an overview of microbiology and strategies to ensure manufacturing operations protect against the potential for microorganism growth and contamination

Recorded March 22, 2016. Member cost: $220. Nonmember cost: $520.

Kombucha: Tax, labeling and legislation

Presented: November 4, 2015

The third in a series of kombucha webinars provides regulatory and technical guidance to the kombucha industry from several industry legal experts.

Proposition 65: What's Going On?

Presented: May 20, 2015

This webinar provides an overview of several significant developments related to California's Proposition 65. Companies that sell products in California should understand these recent changes and be prepared for additional changes that are in development.

Contract Manufacturers and their Customers: Best Practices for Effective Partnerships

Presented November 13, 2014

Dietary supplement contract manufacturers and their “own-label distributor” customers must navigate a host of issues in order to establish effective business partnerships that ensure quality and compliance with federal laws and regulations

FDA Inspections & Emerging cGMP Compliance Issues

Presented May 15, 2014

Tips for handling every aspect of a Food and Drug Administration (FDA) inspection--from pre-inspection preparation to interacting with on-site inspectors--and how to respond to observations and warning letters

Legal experts provide tips for FDA inspections

Presented May 15, 2014

tips for handling every aspect of a FDA inspection, from pre-inspection preparation to interacting with on-site inspectors, and responding to observations and warning letters

FDA cGMP Inspections & Emerging Compliance Issues for Dietary Supplements

Presented: December 19 , 2012

Industry experts will provide attendees with an insider's view of where FDA focuses its efforts during dietary supplement cGMP inspections to help participants fulfilling their all-important compliance efforts.
RSS
1234

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.